MedPath

The Effect of Tranexamic Acid for EL2 after EVAR.

Phase 1
Conditions
Abdominal aortic aneurysm, iliac artery aneurysm
Registration Number
JPRN-jRCTs041180163
Lead Sponsor
IMAEDA YUSUKE
Brief Summary

In this study, we demonstrate that oral TA suppressed the fibrinolytic system in patients who underwent EVAR. However, the EL2 suppressing effect of TA was not proved. Future research shall study EL2 inhibitory effect on patient who underwent EVAR in combination with other factors, such as IMA embolization.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
85
Inclusion Criteria

Patients who undergo first bifurcated stent graft treatment for abdominal aortic aneurysm and iliac artery aneurysm at Aichi Medical University Hospital.

Exclusion Criteria

Patents who cannot take internal medicine.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath